The implications of this development for the lab industry are not entirely clear, but after almost a year spent building out molecular capacities to meet COVID-19 test demand, the question of what to do with that capacity in a post-COVID-19 environment looms on the horizon.
The implications of this development for the lab industry are not entirely clear, but after almost a year spent building out molecular capacities to meet COVID-19 test demand, the question of what to do with that capacity in a post-COVID-19 environment looms on the horizon.
